Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MTI Europe 2010 kicks off

This article was originally published in Clinica

Executive Summary

Tina Tan, editor of Clinica, chaired the morning session today at the 11th Medtech Europe Investing conference. The event, held in London, runs from today until 14 September 2010. It provides a networking environment where investors and innovators can meet to talk business. Delegates included representatives of the point-of-care devices, IVD, biotechnology, imaging and IT sectors. Below are photos from this morning's event; news from the event will be published in the upcoming edition of Clinica Medtech Intelligence.

You may also be interested in...

Visualised: An isotope crisis

Back to Visualised

Visualised: Labelling of medical devices containing phthalates

Back to Visualised

Bluetooth and mobile phones good enough for patient monitoring at home

Existing Bluetooth technology and mobile phones could be effectively deployed in a home setting to monitor patients’ pattern movements, according to two studies highlighted at the recent European Research and Innovation Conference (ERIC) 2010 in Ireland.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts